US20050037079A1 - Temperature sensitive state-changing hydrogel composition and method for preparation - Google Patents
Temperature sensitive state-changing hydrogel composition and method for preparation Download PDFInfo
- Publication number
- US20050037079A1 US20050037079A1 US10/719,935 US71993503A US2005037079A1 US 20050037079 A1 US20050037079 A1 US 20050037079A1 US 71993503 A US71993503 A US 71993503A US 2005037079 A1 US2005037079 A1 US 2005037079A1
- Authority
- US
- United States
- Prior art keywords
- hydrogel
- state
- skin
- hydrogel composition
- changing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 113
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 238000000034 method Methods 0.000 title abstract description 13
- 238000002360 preparation method Methods 0.000 title description 3
- 239000000499 gel Substances 0.000 claims abstract description 59
- 229920000642 polymer Polymers 0.000 claims abstract description 44
- 239000003792 electrolyte Substances 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- -1 Aliphatic Polyol Chemical class 0.000 claims abstract description 10
- 239000012620 biological material Substances 0.000 claims abstract description 10
- 239000013538 functional additive Substances 0.000 claims abstract description 10
- 229920005862 polyol Polymers 0.000 claims abstract description 10
- 239000004615 ingredient Substances 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims description 19
- 230000003796 beauty Effects 0.000 claims description 12
- 229920001661 Chitosan Polymers 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 239000003623 enhancer Substances 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 102000016942 Elastin Human genes 0.000 claims description 5
- 108010014258 Elastin Proteins 0.000 claims description 5
- 229920002549 elastin Polymers 0.000 claims description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 4
- 241001116389 Aloe Species 0.000 claims description 4
- 229920000926 Galactomannan Polymers 0.000 claims description 4
- 229920002581 Glucomannan Polymers 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 4
- 235000011399 aloe vera Nutrition 0.000 claims description 4
- 235000010418 carrageenan Nutrition 0.000 claims description 4
- 239000000679 carrageenan Substances 0.000 claims description 4
- 229920001525 carrageenan Polymers 0.000 claims description 4
- 229940113118 carrageenan Drugs 0.000 claims description 4
- 229940046240 glucomannan Drugs 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- 241000255789 Bombyx mori Species 0.000 claims description 3
- 244000194101 Ginkgo biloba Species 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 3
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 claims description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 3
- 229960004705 kojic acid Drugs 0.000 claims description 3
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 3
- 229960003471 retinol Drugs 0.000 claims description 3
- 235000020944 retinol Nutrition 0.000 claims description 3
- 239000011607 retinol Substances 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 240000000249 Morus alba Species 0.000 claims description 2
- 235000008708 Morus alba Nutrition 0.000 claims description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 2
- 235000011613 Pinus brutia Nutrition 0.000 claims description 2
- 241000018646 Pinus brutia Species 0.000 claims description 2
- 241000241413 Propolis Species 0.000 claims description 2
- 102000016611 Proteoglycans Human genes 0.000 claims description 2
- 108010067787 Proteoglycans Proteins 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 235000009569 green tea Nutrition 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 239000005445 natural material Substances 0.000 claims description 2
- 229940069949 propolis Drugs 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 19
- 229940079593 drug Drugs 0.000 abstract description 12
- 230000036760 body temperature Effects 0.000 abstract description 6
- 239000012530 fluid Substances 0.000 abstract description 5
- 239000000126 substance Substances 0.000 description 23
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 5
- 229920000297 Rayon Polymers 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000002964 rayon Substances 0.000 description 4
- 239000004753 textile Substances 0.000 description 4
- 230000037317 transdermal delivery Effects 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000061354 Manilkara achras Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000110 cooling liquid Substances 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
Definitions
- FIG. 1 shows the viscosity of the Hydrogel composition measured at various temperatures.
- FIG. 2 shows that the hydrogel is formed by two gel type Polymers. Part (a) shows that physical bond of the branched polymer and electrical bond of the electrolyte gel polymer exists together. Part (b) shows the fluid state of the polymers where electrical bond of the electrolyte gel polymer exists but the physical bond of the branched gel polymer does not exist.
- FIG. 3 shows the skin care hydrogel sheet that was produced using invented hydrogel composition.
- Part (a) is the base that is made out of rayon textile and part (b) is the invented Hydrogel.
- This invention is about the temperature sensitive state-changing Hydrogel composition and the method for its preparation.
- it is the Hydrogel composition and its method of production of the gel that transforms into state-changing condition by temperature difference which can be applied efficiently to skin as beauty care.
- the state-changing Hydrogel composition means a material Hydrogel, which contains great quantity of water, changes its form into state of fluid at a certain temperature.
- Hydrogel has been used in many areas of skin-care such as cosmetic products, and dermal treatment. Hydrogel is used as a base frame because it is suitable for the controlled release of drugs (N. A. Pappas Ed., “Hydrogels in Medicine and Pharmacy, Vol.11; Polymers’, CRC Press, Inc., 1987.). This means that Hydrogel is used as a base frame with hormones such as progesterone, and then slowly releases and controls the quantity of the hormones into the body.
- hormones such as progesterone
- Transdermal delivery of drugs is a technique that transfers hormones such as Progesterone, Progestin, Estrogen, and Testosterone into the body through the skin.
- hormones such as Progesterone, Progestin, Estrogen, and Testosterone
- This high level medicating system slowly releases adjusted quantity of medicine into body through transdermal from hydrogel which is attached on the skin.
- Verner U.S. Pat. No. 5,064,654 also introduces the composition of adhesive hydrogel for transdermal delivery of drugs.
- Rolf U.S. Pat. Nos. 6,361,790 and 6,406,712 introduced a patch and dressing method of skin application using hydrogel.
- hydrogel When hydrogel is in the gel state, it takes relatively long time for the medicine to penetrate into skin, and the drug could only be delivered to the limited area where the hydrogel directly contacts the skin.
- hydrogel is used in this skin care system to increase effectiveness, and it is produced in sheet and patch forms to effectively apply to the skin.
- hydrogel is used, there are limitations when hydrogel is in the form of gel. This limitation causes delay in speed and the quantity of the drug delivery.
- This invention is to provide the temperature sensitive state-changing hydrogel which delivers beauty substance into the skin evenly and rapidly.
- the hydrogel composition changes its state into liquid which can flow due to body temperature after skin contact.
- this invention is to provide the production method of temperature sensitive state-changing hydrogel that distributes beauty substance onto skin evenly and rapidly.
- Temperature sensitive hydrogel composition consists of Branched Gel Polymer 1-10 wt %, Electrolyte Gel Polymer 0.5-5 wt %, Skin-friendly Enhancements 0.5-5 wt %, Natural Bio Material 1-10 wt %, Aliphatic Polyol 3-30 wt %, Functional Additive 1-10 wt % and water 30-93 wt % and transforms to the state of fluid at the temperature of 10 ⁇ 50° C.
- Temperature Sensitive State-changing Hydrogel has two steps for its production.
- the first step (Preparation of Gel solution): At room temperature, mix Aliphatic polyol 3-30 wt % with Branched gel polymer 1-10 wt % (extracted from group of Galactomannan, Glucomannan, Guagum, Locastgum and Plutonic), Electrolyte gel polymer 0.5-5 wt % (extracted from group of Aga, Algin, Carrageenan, Xantan and Gelan), Functional Additive 1-10 wt % (extracted from group of Chitosan derivative, Proteoglucan, Elastin, Collagen and Hyaluronic acid), and 30-93 wt % water. Then increase the temperature to 45 ⁇ 95° C.
- the second step While maintaining the temperature at 45 ⁇ 95° C., sequentially add Natural Bio Material 1-10 wt % (extracted from Aloe, Green Tea, Ginseng, Wood Vinegar, Pine Needles, Gingko Leaf, Mulberry Leaf (Silkworm)), Skin-friendly Enhancements 0.5-5 wt % (Extracted from Metilparavin, Propilpaprvin, Kojic acid, ⁇ -Hydroxy Acid and Retinol), and cool it down to room temperature.
- Natural Bio Material 1-10 wt % extracted from Aloe, Green Tea, Ginseng, Wood Vinegar, Pine Needles, Gingko Leaf, Mulberry Leaf (Silkworm)
- Skin-friendly Enhancements 0.5-5 wt % (Extracted from Metilparavin, Propilpaprvin, Kojic acid, ⁇ -Hydroxy Acid and Retinol), and cool it down to room temperature.
- temperature sensitive state-changing hydrogel composition transforms from gel to liquid state at an ideal temperature of 30-40° C., generally 10-50° C. Because it enhances the acceptance level between hydrogel and skin, it delivers beauty substance or medicine evenly and rapidly.
- This invention is to construct ideal and effective method of hydrogel that can be used in short time beauty treatment, and then produce suitable temperature sensitive state-changing hydrogel composition.
- This temperature sensitive state-changing hydrogel composition optimizes acceptance level between hydrogel composition and skin when gel transforms into liquid state after a skincare substance contained hydrogel sheet or patch is applied to skin.
- hydrogel composition contains natural acceptance level enhancements, contented amount of cosmetic can be delivered into transdermal.
- this invented Hydrogel when used in beauty care in a form of hydrogel sheet or patch, the body temperature will change the hydrogel state to liquid so that it becomes a flowable composition. This hydrogel will automatically adhere and penetrate into the skin and increase the acceptance level greatly.
- this invented hydrogel composition includes gel substances that are comprised of tree type and electrolyte polymers together with acceptance level enhancer and natural bio materials to increase the acceptance level with the skin. Also, Polyhydric Alcohol and a functional substance will be added to give the liquid state hydrogel more flux.
- Hydrogel composition consists of Branched Gel Polymer 1-10 wt %, Electrolyte Gel Polymer 0.5-5 wt %, Skin-friendly Enhancements 0.5-5 wt %, Natural Bio Material 1-10 wt %, Aliphatic Polyol 3-30 wt %, Functional Additive 1-10 wt % and water 30-93 wt %.
- hydrogel composition changes its state to liquid by body temperature when it is applied to the skin. It was also found that because of the above characteristics, substances included in hydrogel composition rapidly adhere and penetrate into skin.
- Electrolyte Gel Polymers keeps the invented gel composition to stay in a gel state, and in some cases it keeps invented gel composition to stay in the gel state in room temperature (ideally between 0-30° C.).
- the Branched Gel Polymers acts as a substance to change the state from solid to liquid form when the temperature increases 10-50° C. (ideally 30-40° C.).
- FIG. 2 shows the formation of the two polymers. Part (a) shows that physical bond of the branched gel polymer and electrical bond of the electrolyte gel polymer exists together. Part (b) shows the liquid state of the polymers where electrical bond of the electrolyte gel polymer exists but the physical bond of the branched gel polymer does not exist.
- the Branched gel polymers are water soluble Polysaccharide Polymers which are Galactomannan, Glucomannan, Guagum, Locastgum and Plutonic.
- the Electrolyte gel polymers are Polysaccharide Polymers which are Aga, Algin, Carrageenan, Xantan and Gelan), Functional Additive 1-10 wt %(extracted from group of Chitosan derivative, Proteoglyucans, Elastin, Collagen and Hyaluronic acid.
- the Branched gel polymers have 1-10 wt % and the Electrolyte gel polymers have 0.5-5 wt %. If the composition is not within this range, gel state will not form nor will it change to liquid state even with increase in temperature.
- skin-friendly enhancer will improve the acceptability of the skin to help the drugs to rapidly penetrate into skin, these substance are but not limited to the Polysaccharides like Chitosan, Proteoglycans, Chitosan derivative, Elastin, Collagen, Hyaluronic Acid or other Proteins that can be water soluble.
- the desired quantity of 0.5-5 wt % is based on the total weight of the composition.
- biomaterials are also added to improve the acceptability of the skin. They are natural substances that are extracted from plant, animal or mineral which are as follows but not limited to extracted substance from aloe, green tea, ginseng, wood vinegar, pine needles, propolis, gingko leaves, and mulberry leaves (silkworm).
- the desirable quantities are about 1-10 wt % based on total weight of the composition.
- Aliphatic Polyols like Propylene glycol and glycerine are soluble in water liquid which facilitates hydrogel composition to adhere and penetrate into the skin.
- the desirable quantities are about 3-30 wt % based on total weight. If the alcohol content is more than the desirable amount, formation of the gel state will be a problem. If it is less than the desirable amount, then the problem of stationary state as a gel will arise.
- Functional additives listed below are the additives that can provide stability and functionality. They are propilparavin, Kojic acid, ⁇ -Hydroxy acid, imidazolidinylurea, twin80 and retinol. Desirable quantities are 1-10 wt % based on total weight of the composition. If the additive content are less than the desirable amount, stability will be decreased which would prohibit from long-term storage, and if it has more than the desirable amount, the problem of stationary state as a gel will arise.
- Water is the main substance of the hydrogel composition that is based on total weight of the composition its quantity is about 30-93 wt %. Water content less than the amount will rose a problem of stationary state when the temperature rises, and more water will have a problem of not forming a gel.
- Hydrogel composition comprised as above will have unique characteristics of staying in a gel state in temperature between 0-10° C., and changing to liquid state in 10-50° C. Also this invented hydrogel composition can remain as a gel state at 0-30° C. or at room temperature, and transform to liquid state in 20-40° C. depending upon different amount of substances in the composition. As it was stated above, this invented hydrogel composition is sensitive to temperature difference and has characteristic of changing its states so that skin care substances in the hydrogel composition can rapidly and evenly penetrate into skin when it is applied directly to the skin.
- the Hydrogel composition can be produced by the following method. First, mix Branched gel polymer and electrolyte gel polymer into the Aliphatic Polyol and make the polymer solution, then mix the functional additive to the Aliphatic Polyol and make the functional solution. Combine the two polymer solution and the functional solution and produce the basic mixture solution.
- Next step is to mix the basic mixture solution with the deionized water and heat the solution temperature to 45-95° C. While maintaining the temperature, add the acceptance enhancer and the natural biomaterials to the solution which will produce the liquid state Hydrogel composition.
- the amount of added substance should be as mentioned before, and their benefits have also been mentioned earlier.
- this invented hydrogel composition can be produced as a patch or sheet to be applied to skin.
- gel type hydrogel can be produced by cooling liquid hydrogel composition made in sheet or patch form to a temperature in between 45-95° C.
- FIG. 3 shows the beauty care hydrogel sheet by inserting rayon textile as a wick into hydrogel composition. Part (a) is the rayon textile and part (b) is the invented hydrogel composition.
- FIG. 1 shows the viscosity of the above hydrogel composition measured at various temperatures. As it is shown in FIG. 1 , the hydrogel composition decreases its viscosity when the temperature increases and transforms to liquid state.
- Hydrogel sheet can be produced by adding a rayon textile as a wick to this hydrogel composition at the temperature of 80° C. and then cooling it. This will be used to release beauty care ingredients to the skin.
- hydrogel when hydrogel is applied to skin the coverage is 40-70%. However, due to the characteristic of the invented hydrogel which is temperature sensitive state-changing, it has 100% coverage and faster migration rate of ingredient. It is a product that increases epidermal absorption of hydrogel.
- the invented hydrogel composition is not only very effective in skin care but also effective in skin treatment if rapid delivery of drug or skin-friendly material is required. Especially, the invented hydrogel can be used very effectively in skin care transdermal cosmetic delivery.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
This invention is about temperature sensitive state-changing hydrogel composition and its method of production that consists of Branched Gel Polymer 1-10 wt %, Electrolyte Gel Polymer 0.5-5 wt %, Skin-friendly Enhancements 0.5-5 wt %, Natural Bio Material 1-10 wt %, Aliphatic Polyol 3-30 wt %, Functional Additive 1-10 wt % and water 30-93 wt %. Temperature sensitive hydrogel composition is produced at temperature between 10° C. and 50° C., where hydrogel transforms to a fluid state. When this invented hydrogel composition is contacted with skin, it transforms into a fluid state owing to body temperature. Then the ingredient or medication in hydrogel can efficiently and evenly penetrate into the skin.
Description
-
FIG. 1 shows the viscosity of the Hydrogel composition measured at various temperatures. -
FIG. 2 shows that the hydrogel is formed by two gel type Polymers. Part (a) shows that physical bond of the branched polymer and electrical bond of the electrolyte gel polymer exists together. Part (b) shows the fluid state of the polymers where electrical bond of the electrolyte gel polymer exists but the physical bond of the branched gel polymer does not exist. -
FIG. 3 shows the skin care hydrogel sheet that was produced using invented hydrogel composition. Part (a) is the base that is made out of rayon textile and part (b) is the invented Hydrogel. - This invention is about the temperature sensitive state-changing Hydrogel composition and the method for its preparation. In detail, it is the Hydrogel composition and its method of production of the gel that transforms into state-changing condition by temperature difference which can be applied efficiently to skin as beauty care.
- The state-changing Hydrogel composition means a material Hydrogel, which contains great quantity of water, changes its form into state of fluid at a certain temperature.
- In Recent years, Hydrogel has been used in many areas of skin-care such as cosmetic products, and dermal treatment. Hydrogel is used as a base frame because it is suitable for the controlled release of drugs (N. A. Pappas Ed., “Hydrogels in Medicine and Pharmacy, Vol.11; Polymers’, CRC Press, Inc., 1987.). This means that Hydrogel is used as a base frame with hormones such as progesterone, and then slowly releases and controls the quantity of the hormones into the body.
- According to Sakai U.S. Pat. No. 5,344,655, a procedure to transfer drug through skin into the body using water soluble polymers such as Cellulose Derivative containing hydrogel has been already introduced.
- According to Fox, U.S. Pat. No. 5,405,366, the technique used in transdermal drug delivery system using water soluble polymers, which form an optical bridge, contained adhesive hydrogel were introduced.
- Gebner introduced in U.S. Pat. No. 4,593,053 the usage and production method of Hydrogel that is skin friendly and pressure sensitive.
- Transdermal delivery of drugs is a technique that transfers hormones such as Progesterone, Progestin, Estrogen, and Testosterone into the body through the skin. This high level medicating system slowly releases adjusted quantity of medicine into body through transdermal from hydrogel which is attached on the skin.
- Shumiller U.S. Pat. No. 6,215,374 introduces the composition, method, and the device of the hydrogel for efficient transdermal delivery of drugs.
- Verner U.S. Pat. No. 5,064,654 also introduces the composition of adhesive hydrogel for transdermal delivery of drugs.
- Sapota U.S. Pat. No. 4,942,158 introduced the composition of hydrogel that contains penetration increment additive for better transdermal delivery of drugs.
- Moreover, Rolf U.S. Pat. Nos. 6,361,790 and 6,406,712 introduced a patch and dressing method of skin application using hydrogel.
- All of the above traditional techniques apply hydrogel to skin, but it only releases the medicine slowly to the skin from hydrogel which is in the form of gel.
- When hydrogel is in the gel state, it takes relatively long time for the medicine to penetrate into skin, and the drug could only be delivered to the limited area where the hydrogel directly contacts the skin.
- To overcome this disadvantage, a penetration enhancer was added or skin friendly hydrogel was used.
- Generally, unlike medical treatment on skin, when using cosmetic product for skin care a protection device is not applied for long time use on an area of the skin. It is rather applied for a short period and then removed. Hydrogel is used in this skin care system to increase effectiveness, and it is produced in sheet and patch forms to effectively apply to the skin. However, even though hydrogel is used, there are limitations when hydrogel is in the form of gel. This limitation causes delay in speed and the quantity of the drug delivery.
- The friendliness between hydrogel and skin greatly effects delivery of contained drugs or medicine in hydrogel. This means, greater the acceptances faster and more effective delivery of the medicine, and lesser the acceptances slower and less effective delivery of the medicine.
- When applying skincare substance contained hydrogel for beauty treatment onto skin, it needs to be removed sooner than the medical treatment product. That is, the beauty treatment hydrogel needs to deliver the substance to the skin fast and effectively. To fulfill this feature, the hydrogel needs to evenly and rapidly deliver the substance. Therefore, an innovative hydrogel that can fulfill the above characteristics is required.
- This invention is to provide the temperature sensitive state-changing hydrogel which delivers beauty substance into the skin evenly and rapidly. The hydrogel composition changes its state into liquid which can flow due to body temperature after skin contact.
- Also this invention is to provide the production method of temperature sensitive state-changing hydrogel that distributes beauty substance onto skin evenly and rapidly.
- Temperature sensitive hydrogel composition consists of Branched Gel Polymer 1-10 wt %, Electrolyte Gel Polymer 0.5-5 wt %, Skin-friendly Enhancements 0.5-5 wt %, Natural Bio Material 1-10 wt %, Aliphatic Polyol 3-30 wt %, Functional Additive 1-10 wt % and water 30-93 wt % and transforms to the state of fluid at the temperature of 10˜50° C.
- Temperature Sensitive State-changing Hydrogel has two steps for its production.
- The first step (Preparation of Gel solution): At room temperature, mix Aliphatic polyol 3-30 wt % with Branched gel polymer 1-10 wt % (extracted from group of Galactomannan, Glucomannan, Guagum, Locastgum and Plutonic), Electrolyte gel polymer 0.5-5 wt % (extracted from group of Aga, Algin, Carrageenan, Xantan and Gelan), Functional Additive 1-10 wt % (extracted from group of Chitosan derivative, Proteoglucan, Elastin, Collagen and Hyaluronic acid), and 30-93 wt % water. Then increase the temperature to 45˜95° C.
- The second step: While maintaining the temperature at 45˜95° C., sequentially add Natural Bio Material 1-10 wt % (extracted from Aloe, Green Tea, Ginseng, Wood Vinegar, Pine Needles, Gingko Leaf, Mulberry Leaf (Silkworm)), Skin-friendly Enhancements 0.5-5 wt % (Extracted from Metilparavin, Propilpaprvin, Kojic acid, α-Hydroxy Acid and Retinol), and cool it down to room temperature.
- Detailed instructions are explained below.
- The characteristic of temperature sensitive state-changing hydrogel composition is that it transforms from gel to liquid state at an ideal temperature of 30-40° C., generally 10-50° C. Because it enhances the acceptance level between hydrogel and skin, it delivers beauty substance or medicine evenly and rapidly.
- This invention is to construct ideal and effective method of hydrogel that can be used in short time beauty treatment, and then produce suitable temperature sensitive state-changing hydrogel composition.
- This temperature sensitive state-changing hydrogel composition optimizes acceptance level between hydrogel composition and skin when gel transforms into liquid state after a skincare substance contained hydrogel sheet or patch is applied to skin.
- And since this hydrogel composition contains natural acceptance level enhancements, contented amount of cosmetic can be delivered into transdermal.
- Therefore this study provides new hydrogel that has characteristic of temperature sensitive hydrogel that transforms its state from gel to liquid when it reaches certain temperature.
- Especially, when this invented Hydrogel is used in beauty care in a form of hydrogel sheet or patch, the body temperature will change the hydrogel state to liquid so that it becomes a flowable composition. This hydrogel will automatically adhere and penetrate into the skin and increase the acceptance level greatly.
- To obtain the above characteristics, this invented hydrogel composition includes gel substances that are comprised of tree type and electrolyte polymers together with acceptance level enhancer and natural bio materials to increase the acceptance level with the skin. Also, Polyhydric Alcohol and a functional substance will be added to give the liquid state hydrogel more flux.
- Based on the total weight, Hydrogel composition consists of Branched Gel Polymer 1-10 wt %, Electrolyte Gel Polymer 0.5-5 wt %, Skin-friendly Enhancements 0.5-5 wt %, Natural Bio Material 1-10 wt %, Aliphatic Polyol 3-30 wt %, Functional Additive 1-10 wt % and water 30-93 wt %.
- The inventors found out that when the above stated elements are included in hydrogel composition in above mentioned proportion, hydrogel composition changes its state to liquid by body temperature when it is applied to the skin. It was also found that because of the above characteristics, substances included in hydrogel composition rapidly adhere and penetrate into skin.
- For the invented hydrogel composition, Branched Gel Polymers and Electrolyte Gel Polymers are used as gel type substances. The Electrolyte Gel Polymers keeps the invented gel composition to stay in a gel state, and in some cases it keeps invented gel composition to stay in the gel state in room temperature (ideally between 0-30° C.).
- The Branched Gel Polymers acts as a substance to change the state from solid to liquid form when the temperature increases 10-50° C. (ideally 30-40° C.).
FIG. 2 shows the formation of the two polymers. Part (a) shows that physical bond of the branched gel polymer and electrical bond of the electrolyte gel polymer exists together. Part (b) shows the liquid state of the polymers where electrical bond of the electrolyte gel polymer exists but the physical bond of the branched gel polymer does not exist. - The Branched gel polymers are water soluble Polysaccharide Polymers which are Galactomannan, Glucomannan, Guagum, Locastgum and Plutonic. The Electrolyte gel polymers are Polysaccharide Polymers which are Aga, Algin, Carrageenan, Xantan and Gelan), Functional Additive 1-10 wt %(extracted from group of Chitosan derivative, Proteoglyucans, Elastin, Collagen and Hyaluronic acid.
- Based on total weight, the Branched gel polymers have 1-10 wt % and the Electrolyte gel polymers have 0.5-5 wt %. If the composition is not within this range, gel state will not form nor will it change to liquid state even with increase in temperature.
- Below stated skin-friendly enhancer will improve the acceptability of the skin to help the drugs to rapidly penetrate into skin, these substance are but not limited to the Polysaccharides like Chitosan, Proteoglycans, Chitosan derivative, Elastin, Collagen, Hyaluronic Acid or other Proteins that can be water soluble. The desired quantity of 0.5-5 wt % is based on the total weight of the composition. These skin-friendly enhancers are less effective if the substances contained less than desirable amount, and also there will be a problem of stationary state as a gel if the substances contained more than the desirable amount.
- Like the skin-friendly enhancers, below natural biomaterials are also added to improve the acceptability of the skin. They are natural substances that are extracted from plant, animal or mineral which are as follows but not limited to extracted substance from aloe, green tea, ginseng, wood vinegar, pine needles, propolis, gingko leaves, and mulberry leaves (silkworm). The desirable quantities are about 1-10 wt % based on total weight of the composition. These natural biomaterials are less effective if the substances contain less than desirable amount, but also there will be a problem of stationary state as a gel if the substances contain more than desirable amount.
- Aliphatic Polyols like Propylene glycol and glycerine are soluble in water liquid which facilitates hydrogel composition to adhere and penetrate into the skin. The desirable quantities are about 3-30 wt % based on total weight. If the alcohol content is more than the desirable amount, formation of the gel state will be a problem. If it is less than the desirable amount, then the problem of stationary state as a gel will arise.
- Functional additives listed below are the additives that can provide stability and functionality. They are propilparavin, Kojic acid, α-Hydroxy acid, imidazolidinylurea, twin80 and retinol. Desirable quantities are 1-10 wt % based on total weight of the composition. If the additive content are less than the desirable amount, stability will be decreased which would prohibit from long-term storage, and if it has more than the desirable amount, the problem of stationary state as a gel will arise.
- Water is the main substance of the hydrogel composition that is based on total weight of the composition its quantity is about 30-93 wt %. Water content less than the amount will rose a problem of stationary state when the temperature rises, and more water will have a problem of not forming a gel.
- Hydrogel composition comprised as above will have unique characteristics of staying in a gel state in temperature between 0-10° C., and changing to liquid state in 10-50° C. Also this invented hydrogel composition can remain as a gel state at 0-30° C. or at room temperature, and transform to liquid state in 20-40° C. depending upon different amount of substances in the composition. As it was stated above, this invented hydrogel composition is sensitive to temperature difference and has characteristic of changing its states so that skin care substances in the hydrogel composition can rapidly and evenly penetrate into skin when it is applied directly to the skin.
- The Hydrogel composition can be produced by the following method. First, mix Branched gel polymer and electrolyte gel polymer into the Aliphatic Polyol and make the polymer solution, then mix the functional additive to the Aliphatic Polyol and make the functional solution. Combine the two polymer solution and the functional solution and produce the basic mixture solution.
- Next step is to mix the basic mixture solution with the deionized water and heat the solution temperature to 45-95° C. While maintaining the temperature, add the acceptance enhancer and the natural biomaterials to the solution which will produce the liquid state Hydrogel composition. The amount of added substance should be as mentioned before, and their benefits have also been mentioned earlier.
- Also, this invented hydrogel composition can be produced as a patch or sheet to be applied to skin. For example, to apply this invented hydrogel composition as a beauty care product, gel type hydrogel can be produced by cooling liquid hydrogel composition made in sheet or patch form to a temperature in between 45-95° C.
FIG. 3 shows the beauty care hydrogel sheet by inserting rayon textile as a wick into hydrogel composition. Part (a) is the rayon textile and part (b) is the invented hydrogel composition. - When this invented hydrogel sheet or patch is applied to the skin, the hydrogel will transform its state from gel to liquid by the body temperature which will add the flux to the hydrogel. Because this invented state-changing hydrogel changes to the liquid state by the body temperature when it is applied to the skin, this will let the hydrogel automatically adhere to the skin and the skin will accept more of the substance. Therefore, it is more effective in skin care than traditional hydrogel.
- Below examples explains this invention in more detail. However, this does not limit the inventions categories.
- Mix glycerine 170 g, Carrageenan 6 g and Locastgum 20 g at room temperature and stir in a 3 liter heatable container. Add to the mixture solution glycerine 30 g, metilparaben 0.8 g, propileparaben 0.3 g. Add 740 g of deionized water and heat the solution to 85° C. This will be the gel solution.
- While maintaining the temperature at 85° C., add sequentially aloe extraction 20 g, collagen 5 g, imidazolidinylurea 2 g, twin80 1.5 g, and chitosan 3.7 g to the gel solution. This is the hydrogel composition.
FIG. 1 shows the viscosity of the above hydrogel composition measured at various temperatures. As it is shown inFIG. 1 , the hydrogel composition decreases its viscosity when the temperature increases and transforms to liquid state. - Hydrogel sheet can be produced by adding a rayon textile as a wick to this hydrogel composition at the temperature of 80° C. and then cooling it. This will be used to release beauty care ingredients to the skin.
- Generally, when hydrogel is applied to skin the coverage is 40-70%. However, due to the characteristic of the invented hydrogel which is temperature sensitive state-changing, it has 100% coverage and faster migration rate of ingredient. It is a product that increases epidermal absorption of hydrogel.
- In the case of this invention, it is considered that additional explanation about epidermal absorption is needed when the hydrogel is applied to skin. However, please note that in a case when sufficient time is necessary for the concrete experiment and data entry, application should be submitted as it is. Then it could be reapplied within a year with domestic priority assertion.
- The invented hydrogel composition is not only very effective in skin care but also effective in skin treatment if rapid delivery of drug or skin-friendly material is required. Especially, the invented hydrogel can be used very effectively in skin care transdermal cosmetic delivery.
Claims (8)
1. Temperature sensitive state-changing hydrogel composition, comprising of;
(a) branched gel polymer 1-10 wt %;
(b) electrolyte gel polymer 0.5-5 wt %;
(c) skin-friendly enhancements 0.5-5 wt %;
(d) natural bio material 1-10 wt %;
(e) aliphatic polyol 3-30 wt %;
(f) functional additive 1-10 wt %; and
(g) water 30-93 wt %.
2. State-changing hydrogel composition according to claim 1 , wherein said the Branched gel polymer, one of the Hydrogel ingredient, is water soluble Polysaccharide Polymers which are selected from at least one from the group of Galactomannan, Glucomannan, Guagum, Locastgum and Plutonic.
3. State-changing hydrogel composition according to claim 1 , the Electrolyte gel polymer, one of the Hydrogel ingredient, is the Polysaccharide Polymers which are selected from at least one from the group of Aga, Algin, Carrageenan, Xantan and Gelan.
4. State-changing hydrogel composition according to claim 1 , Skin-friendly enhancer, one of the Hydrogel ingredient, is selected from at least one from the group of Polysaccharide like Chitosan, proteoglycans, Chitosan derivative, Elastin, Collagen, Hyaluronic Acid or other Proteins.
5. State-changing hydrogel composition according to claim 1 , Natural bio materials, one of the Hydrogel ingredient, is the natural substance extracted from plant, animal or mineral which are aloe, green tea, ginseng, wood vinegar, pine needles, propolis, gingko leaves, and mulberry leaves (silkworm).
6. State-changing hydrogel composition according to claim 1 , Aliphatic Polyol, one of the Hydrogel ingredients, is liquid Propylene glycol or liquid glycerine which are water soluble.
7. State-changing hydrogel composition according to claim 1 , Functional additive, one of the Hydrogel ingredient, is the additive that can provide stability and beauty care functionality. They are propilparavin, Kojic acid, α-Hydroxy acid, imidazolidinylurea, twin80 and retinol.
8. Temperature Sensitive State-changing Hydrogel production method is as follows:
At the room temperature, mixing Aliphatic Polyol 3-30 wt % with branched gel polymer 1-10 wt % (extracted from group of Galactomannan, Glucomannan, Guagum, Locastgum and Plutonic), Electrolyte gel polymer 0.5-5 wt % (extracted from group of Aga, Aglin, Carragenan, Xantan and Gelan), Functional Additive 1-10 wt % (extracted from group of Chitosan derivative, Proteoglucan, Elastin, Collagen and Hyaluronic acid), and adding between about 30-93 wt % water;
increasing the temperature to 45˜95° C.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2003-0056557A KR100506543B1 (en) | 2003-08-14 | 2003-08-14 | Temperature Sensitive State-Changing Hydrogel Composition and Method for their Preparation |
| KR10-2003-0056557 | 2003-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20050037079A1 true US20050037079A1 (en) | 2005-02-17 |
Family
ID=36168657
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/719,935 Abandoned US20050037079A1 (en) | 2003-08-14 | 2003-11-21 | Temperature sensitive state-changing hydrogel composition and method for preparation |
| US10/567,483 Expired - Lifetime US8663664B2 (en) | 2003-08-14 | 2004-09-13 | Temperature sensitive state-changing hydrogel composition and method for their preparation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/567,483 Expired - Lifetime US8663664B2 (en) | 2003-08-14 | 2004-09-13 | Temperature sensitive state-changing hydrogel composition and method for their preparation |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20050037079A1 (en) |
| EP (1) | EP1653921B1 (en) |
| JP (1) | JP4959328B2 (en) |
| KR (1) | KR100506543B1 (en) |
| CN (1) | CN100467011C (en) |
| RU (1) | RU2320318C2 (en) |
| WO (1) | WO2005016305A1 (en) |
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060036271A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification devices |
| US20070123890A1 (en) * | 2005-11-04 | 2007-05-31 | X-Sten, Corp. | Tissue retrieval devices and methods |
| US20070280974A1 (en) * | 2003-08-14 | 2007-12-06 | Genic Co.,Ltd | Temperature Sensitive State-Changing Hydrogel Composition and Method for Their Preparation |
| US20080221383A1 (en) * | 2007-02-12 | 2008-09-11 | Vertos Medical, Inc. | Tissue excision devices and methods |
| US20090036936A1 (en) * | 2006-05-09 | 2009-02-05 | Vertos Medical, Inc. | Translaminar approach to minimally invasive ligament decompression procedure |
| WO2009024275A1 (en) * | 2007-08-20 | 2009-02-26 | Ics Innovative Care Systems Andernach Gmbh | Water- and active ingredient-containing gel |
| WO2009038030A1 (en) * | 2007-09-20 | 2009-03-26 | Fujifilm Corporation | Gel sheet and sheet-like cosmetic material using the same |
| US20090110656A1 (en) * | 2007-10-31 | 2009-04-30 | Lemke Sarah A | Skin cooling composition |
| US20090118709A1 (en) * | 2007-11-06 | 2009-05-07 | Vertos Medical, Inc. A Delaware Corporation | Tissue Excision Tool, Kits and Methods of Using the Same |
| WO2009037947A3 (en) * | 2007-09-20 | 2009-07-23 | Fujifilm Corp | Adhesive gel sheet for living organisms and sheet form cosmetics comprising the same |
| USD598549S1 (en) | 2008-09-16 | 2009-08-18 | Vertos Medical, Inc. | Surgical trocar |
| USD606654S1 (en) | 2006-07-31 | 2009-12-22 | Vertos Medical, Inc. | Tissue excision device |
| USD610259S1 (en) | 2008-10-23 | 2010-02-16 | Vertos Medical, Inc. | Tissue modification device |
| USD611146S1 (en) | 2008-10-23 | 2010-03-02 | Vertos Medical, Inc. | Tissue modification device |
| USD619252S1 (en) | 2008-10-23 | 2010-07-06 | Vertos Medical, Inc. | Tissue modification device |
| USD619253S1 (en) | 2008-10-23 | 2010-07-06 | Vertos Medical, Inc. | Tissue modification device |
| USD620593S1 (en) | 2006-07-31 | 2010-07-27 | Vertos Medical, Inc. | Tissue excision device |
| USD621939S1 (en) | 2008-10-23 | 2010-08-17 | Vertos Medical, Inc. | Tissue modification device |
| US8696671B2 (en) | 2005-07-29 | 2014-04-15 | Vertos Medical Inc. | Percutaneous tissue excision devices |
| WO2017095366A1 (en) * | 2015-11-30 | 2017-06-08 | Kimberly-Clark Worldwide, Inc. | Structures containing thermo-sensitive gels |
| US10433700B2 (en) | 2013-11-27 | 2019-10-08 | Kimberly-Clark Worldwide, Inc. | Multi-purpose tough stain removal articles |
| CN112029118A (en) * | 2020-08-27 | 2020-12-04 | 新疆赛诺凯生物科技有限公司 | Wood vinegar-carbon aerogel composite hydrogel film and preparation method and application thereof |
| US12102348B2 (en) | 2016-09-07 | 2024-10-01 | Vertos Medical, Inc. | Percutaneous lateral recess resection methods and instruments |
| US12324572B2 (en) | 2022-06-16 | 2025-06-10 | Vertos Medical, Inc. | Integrated instrument assembly |
| US12496085B2 (en) | 2024-09-05 | 2025-12-16 | Vertos Medical, Inc. | Percutaneous lateral recess resection methods and instruments |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8784336B2 (en) | 2005-08-24 | 2014-07-22 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
| US8388546B2 (en) | 2006-10-23 | 2013-03-05 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
| US7794407B2 (en) | 2006-10-23 | 2010-09-14 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
| KR100848712B1 (en) * | 2007-03-30 | 2008-07-28 | 강원대학교산학협력단 | Photo-crosslinkable temperature sensitive hydrogel composition and its preparation method |
| JP5653573B2 (en) * | 2007-09-20 | 2015-01-14 | 富士フイルム株式会社 | Gel sheet and sheet cosmetic using the same |
| US9521961B2 (en) | 2007-11-26 | 2016-12-20 | C. R. Bard, Inc. | Systems and methods for guiding a medical instrument |
| US10751509B2 (en) | 2007-11-26 | 2020-08-25 | C. R. Bard, Inc. | Iconic representations for guidance of an indwelling medical device |
| US8781555B2 (en) | 2007-11-26 | 2014-07-15 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
| US10449330B2 (en) | 2007-11-26 | 2019-10-22 | C. R. Bard, Inc. | Magnetic element-equipped needle assemblies |
| US10524691B2 (en) | 2007-11-26 | 2020-01-07 | C. R. Bard, Inc. | Needle assembly including an aligned magnetic element |
| EP2712547B1 (en) | 2007-11-26 | 2015-09-30 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
| US8849382B2 (en) | 2007-11-26 | 2014-09-30 | C. R. Bard, Inc. | Apparatus and display methods relating to intravascular placement of a catheter |
| US9649048B2 (en) | 2007-11-26 | 2017-05-16 | C. R. Bard, Inc. | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
| CL2008000156A1 (en) * | 2008-01-18 | 2008-08-01 | Igloo Zone Chile S A | STABLE HYDROPHYLE GEL BASED ON A POLYMER FOR TOPICAL APPLICATION BECAUSE IT INCLUDES DISSOLVED CHITOSANE IN A SOLVENT; PROCESS TO OBTAIN THE GEL FOR TOPICAL USE BEFORE MENTIONED; USE OF THE GEL. |
| US8478382B2 (en) | 2008-02-11 | 2013-07-02 | C. R. Bard, Inc. | Systems and methods for positioning a catheter |
| KR101104901B1 (en) | 2008-05-23 | 2012-01-12 | 김영곤 | Method for producing active drug-release thermorod and thermorod manufactured thereby |
| EP2313143B1 (en) | 2008-08-22 | 2014-09-24 | C.R. Bard, Inc. | Catheter assembly including ecg sensor and magnetic assemblies |
| US8437833B2 (en) | 2008-10-07 | 2013-05-07 | Bard Access Systems, Inc. | Percutaneous magnetic gastrostomy |
| KR101729139B1 (en) * | 2008-11-28 | 2017-05-08 | (주)아모레퍼시픽 | Hydrogel Pad containing Natural Materials |
| BRPI1010773B1 (en) | 2009-06-12 | 2021-06-01 | Bard Access Systems, Inc | ADAPTER FOR ENDOVASCULAR ELECTROCARDIOGRAPHY CROSS REFERENCE FOR RELATED ORDER |
| US9532724B2 (en) | 2009-06-12 | 2017-01-03 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
| EP2464407A4 (en) | 2009-08-10 | 2014-04-02 | Bard Access Systems Inc | Devices and methods for endovascular electrography |
| CN102665541B (en) | 2009-09-29 | 2016-01-13 | C·R·巴德股份有限公司 | The probe used together with the equipment that the Ink vessel transfusing for conduit is placed |
| US11103213B2 (en) | 2009-10-08 | 2021-08-31 | C. R. Bard, Inc. | Spacers for use with an ultrasound probe |
| JP2013518676A (en) | 2010-02-02 | 2013-05-23 | シー・アール・バード・インコーポレーテッド | Apparatus and method for locating catheter navigation and tip |
| ES2778041T3 (en) | 2010-05-28 | 2020-08-07 | Bard Inc C R | Apparatus for use with needle insertion guidance system |
| EP2912999B1 (en) | 2010-05-28 | 2022-06-29 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
| CN103228219B (en) | 2010-08-09 | 2016-04-27 | C·R·巴德股份有限公司 | Support and Covering Structures for Ultrasound Probe Heads |
| US20120046562A1 (en) | 2010-08-20 | 2012-02-23 | C. R. Bard, Inc. | Reconfirmation of ecg-assisted catheter tip placement |
| CN103189009B (en) | 2010-10-29 | 2016-09-07 | C·R·巴德股份有限公司 | Bioimpedance Assisted Placement of Medical Devices |
| JP6008960B2 (en) | 2011-07-06 | 2016-10-19 | シー・アール・バード・インコーポレーテッドC R Bard Incorporated | Needle length determination and calibration for insertion guidance systems |
| USD699359S1 (en) | 2011-08-09 | 2014-02-11 | C. R. Bard, Inc. | Ultrasound probe head |
| USD724745S1 (en) | 2011-08-09 | 2015-03-17 | C. R. Bard, Inc. | Cap for an ultrasound probe |
| KR101367105B1 (en) * | 2011-10-04 | 2014-02-26 | 주식회사 제닉 | Hydrogel Composition For Holding Object And Method For Preparing Hydrogel Using the Same |
| KR101367608B1 (en) * | 2011-10-11 | 2014-03-05 | 주식회사 제닉 | Emulsified Hydrogel Composition and Preparing Method thereof |
| US9211107B2 (en) | 2011-11-07 | 2015-12-15 | C. R. Bard, Inc. | Ruggedized ultrasound hydrogel insert |
| JP6090160B2 (en) * | 2012-02-08 | 2017-03-08 | 東レ株式会社 | Stimulus responsive material and medical material using the same |
| US10820885B2 (en) | 2012-06-15 | 2020-11-03 | C. R. Bard, Inc. | Apparatus and methods for detection of a removable cap on an ultrasound probe |
| KR101462390B1 (en) * | 2012-06-27 | 2014-11-17 | 코스맥스 주식회사 | Skin temperature-sensitive hydrogel composition and a preparing method thereof |
| KR101313430B1 (en) * | 2012-10-15 | 2013-10-01 | 주식회사 케이티에이치아시아 | Hydrogel composition and method for their preparation |
| KR101339622B1 (en) * | 2012-11-13 | 2013-12-09 | 유창석 | Hydrogel composition and method for their preparation |
| KR101453191B1 (en) * | 2013-01-25 | 2014-10-22 | 주식회사 엘지생활건강 | Thermosensitive cosmetic composition |
| KR101467313B1 (en) * | 2013-03-26 | 2014-12-01 | (주)메디웨이코리아 | Composition for Skin Velvet using natural polymer, preparation method of Skin Velvet using thereof and Skin Velvet manufactured by the same |
| KR101502912B1 (en) * | 2013-09-06 | 2015-03-16 | 재단법인대구경북과학기술원 | Mask pack using temperature-responsive sol-gel transfer hydro-gel |
| CN104434544A (en) * | 2013-09-16 | 2015-03-25 | 詹尼克公司 | Gel mask using lace sheet |
| KR101602331B1 (en) * | 2013-09-16 | 2016-03-11 | 주식회사 제닉 | Hydrogel mask pack using lace sheet |
| CN105979868B (en) | 2014-02-06 | 2020-03-10 | C·R·巴德股份有限公司 | Systems and methods for guidance and placement of endovascular devices |
| KR101602049B1 (en) | 2014-08-11 | 2016-03-09 | 주식회사 래디안 | Method for production of double layer hydrogel mask pack |
| US10973584B2 (en) | 2015-01-19 | 2021-04-13 | Bard Access Systems, Inc. | Device and method for vascular access |
| WO2016210325A1 (en) | 2015-06-26 | 2016-12-29 | C.R. Bard, Inc. | Connector interface for ecg-based catheter positioning system |
| CN105287354B (en) * | 2015-11-02 | 2018-05-18 | 嘉文丽(福建)化妆品有限公司 | A kind of preparation method of mask material without adding mask essence |
| KR101768707B1 (en) | 2015-12-29 | 2017-08-16 | 주식회사 케이티에이치아시아 | Manufacturing method of menstrual pain relief patch thereof |
| KR101768709B1 (en) | 2015-12-30 | 2017-08-16 | 주식회사 케이티에이치아시아 | Swelling calves relief patch and manufacturing method of same |
| KR101768708B1 (en) | 2015-12-30 | 2017-08-16 | 주식회사 케이티에이치아시아 | Relaxation of hangove patch and manufacturing method of same |
| US11000207B2 (en) | 2016-01-29 | 2021-05-11 | C. R. Bard, Inc. | Multiple coil system for tracking a medical device |
| KR101909080B1 (en) * | 2016-09-05 | 2018-10-17 | 이은주 | Patch for protecting ultraviolet ray and maintaining skin temperature |
| KR101861555B1 (en) | 2016-12-21 | 2018-05-29 | 주식회사코리아코스팩 | The triple-layered hydrogel mask pack |
| KR102130482B1 (en) * | 2017-10-26 | 2020-07-17 | 손동우 | Water Soluble Gel Sheets and Manufacturing method thereof |
| KR102152300B1 (en) | 2017-11-22 | 2020-09-04 | 주식회사 에?뼛黴보俟? | Rice mask pack sheet and manufacturing method thereof |
| CN108478485A (en) * | 2018-05-04 | 2018-09-04 | 邵立坤 | A kind of temperature-sensitive hydrogel facial mask and preparation method thereof |
| TWI690332B (en) * | 2018-09-20 | 2020-04-11 | 國立清華大學 | Hybrid hydrogel and method of fabricating the same |
| KR102066799B1 (en) * | 2018-09-21 | 2020-01-15 | 중앙대학교 산학협력단 | Thermosensitive water pump system |
| CN112867443B (en) | 2018-10-16 | 2024-04-26 | 巴德阿克塞斯系统股份有限公司 | Safety equipment connection system and method for establishing electrical connection |
| KR102062093B1 (en) * | 2018-10-19 | 2020-01-03 | 숭실대학교 산학협력단 | Multi-layer and multi-compartmented self-transforming mask pack and method of manufacturing the same |
| KR102212669B1 (en) * | 2020-04-29 | 2021-02-05 | (주)바이오다인 | cell inspection method using jellification of alcohol-based solution composition |
| RU2732241C1 (en) * | 2020-05-06 | 2020-09-14 | Общество с ограниченной ответственностью "ГельПласт" | Biodegradable therapeutic hydrogel plate and method for production thereof (embodiments) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4291025A (en) * | 1980-04-11 | 1981-09-22 | Laclede Professional Products, Inc. | Agar gel topical dressing |
| US20030157088A1 (en) * | 2001-11-13 | 2003-08-21 | The Proctor & Gamble Company | Compositions containing enzymes stabilized with inhibitors having certain binding properties and methods for using such compositions in personal care |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4517216A (en) * | 1984-03-05 | 1985-05-14 | Merck & Co., Inc. | Gellan gum/gelatin blends |
| JPS60246314A (en) | 1984-05-21 | 1985-12-06 | Mitsubishi Acetate Co Ltd | Gel plate |
| US4593053A (en) | 1984-12-07 | 1986-06-03 | Medtronic, Inc. | Hydrophilic pressure sensitive biomedical adhesive composition |
| JPS62123112A (en) * | 1985-11-22 | 1987-06-04 | Sunstar Inc | Ointment base |
| JPS63104914A (en) | 1986-10-23 | 1988-05-10 | Mitsubishi Kasei Corp | skin preparations |
| US5064654A (en) | 1989-01-11 | 1991-11-12 | Ciba-Geigy Corporation | Mixed solvent mutually enhanced transdermal therapeutic system |
| US4942158A (en) | 1988-10-13 | 1990-07-17 | Eastman Kodak | Transdermal steroid penetrant compositions and methods utilizing isopropanol and isobutanol |
| DE3903672C1 (en) * | 1989-02-08 | 1990-02-01 | Lohmann Gmbh & Co Kg | |
| JP2761936B2 (en) | 1989-08-24 | 1998-06-04 | 株式会社コーセー | Packing agent |
| JP3046346B2 (en) | 1990-03-12 | 2000-05-29 | 昭和電工株式会社 | External preparation base or auxiliary agent and human or animal external preparation containing it |
| US5804213A (en) | 1991-10-09 | 1998-09-08 | Lectec Corporation | Biologically active aqueous gel wound dressing |
| JPH07501103A (en) | 1991-11-12 | 1995-02-02 | ネペラ インコーポレイテッド | Adhesive hydrogel with long service life and its preparation method |
| AU682827B2 (en) * | 1992-09-18 | 1997-10-23 | Astellas Pharma Inc. | Sustained-release hydrogel preparation |
| US5536263A (en) | 1994-03-30 | 1996-07-16 | Lectec Corporation | Non-occulusive adhesive patch for applying medication to the skin |
| US5840338A (en) * | 1994-07-18 | 1998-11-24 | Roos; Eric J. | Loading of biologically active solutes into polymer gels |
| JP4279361B2 (en) | 1995-04-21 | 2009-06-17 | 小林製薬株式会社 | Hydrogel base for skin application |
| AU2583397A (en) * | 1996-04-10 | 1997-10-29 | Chronorx, Llc | Unit dosage forms, containing magnesium, vitamin c, vitamin e, folate and selenium, for treatment of vasoconstriction and related conditions |
| US5958420A (en) * | 1997-03-13 | 1999-09-28 | Nortrade Medical, Inc. | Treatment of burns, cuts, and abrasions of the skin |
| US6107537A (en) * | 1997-09-10 | 2000-08-22 | The Procter & Gamble Company | Disposable absorbent articles providing a skin condition benefit |
| US7658942B2 (en) * | 2000-04-12 | 2010-02-09 | The Procter & Gamble Company | Cosmetic devices |
| WO2002067856A2 (en) * | 2001-02-23 | 2002-09-06 | University Of Massachusetts | Injection molding of living tissues |
| GB0107655D0 (en) * | 2001-03-27 | 2001-05-16 | Bristol Myers Squibb Co | Wound dressing |
| JP2003113036A (en) | 2001-10-03 | 2003-04-18 | Shiseido Co Ltd | Gel-like composition |
| US6664301B1 (en) * | 2002-02-20 | 2003-12-16 | Robert D. Kross | Method for using glycol additives to texturally modify natural gum hydrogels |
| KR100506543B1 (en) * | 2003-08-14 | 2005-08-05 | 주식회사 제닉 | Temperature Sensitive State-Changing Hydrogel Composition and Method for their Preparation |
-
2003
- 2003-08-14 KR KR10-2003-0056557A patent/KR100506543B1/en not_active Expired - Lifetime
- 2003-11-21 US US10/719,935 patent/US20050037079A1/en not_active Abandoned
-
2004
- 2004-08-13 JP JP2006523132A patent/JP4959328B2/en not_active Expired - Lifetime
- 2004-08-13 EP EP04774311.7A patent/EP1653921B1/en not_active Expired - Lifetime
- 2004-08-13 CN CNB2004800233788A patent/CN100467011C/en not_active Expired - Fee Related
- 2004-08-13 RU RU2006107928/15A patent/RU2320318C2/en active
- 2004-08-13 WO PCT/KR2004/002034 patent/WO2005016305A1/en not_active Ceased
- 2004-09-13 US US10/567,483 patent/US8663664B2/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4291025A (en) * | 1980-04-11 | 1981-09-22 | Laclede Professional Products, Inc. | Agar gel topical dressing |
| US20030157088A1 (en) * | 2001-11-13 | 2003-08-21 | The Proctor & Gamble Company | Compositions containing enzymes stabilized with inhibitors having certain binding properties and methods for using such compositions in personal care |
Cited By (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070280974A1 (en) * | 2003-08-14 | 2007-12-06 | Genic Co.,Ltd | Temperature Sensitive State-Changing Hydrogel Composition and Method for Their Preparation |
| US8663664B2 (en) * | 2003-08-14 | 2014-03-04 | Genic Co., Ltd | Temperature sensitive state-changing hydrogel composition and method for their preparation |
| US20060036271A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification devices |
| US20060206115A1 (en) * | 2004-07-29 | 2006-09-14 | X-Sten | Ligament decompression kit with contrast |
| US20060235452A1 (en) * | 2004-07-29 | 2006-10-19 | X-Sten | Ligament Decompression Tool with Tissue Removal Device |
| US20060036211A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification kit |
| US20070198019A1 (en) * | 2004-07-29 | 2007-08-23 | X-Sten Corp. | Spinal ligament modification devices |
| US20060184175A1 (en) * | 2004-07-29 | 2006-08-17 | X-Sten, Inc. | Spinal ligament modification devices |
| US7896879B2 (en) | 2004-07-29 | 2011-03-01 | Vertos Medical, Inc. | Spinal ligament modification |
| US8882772B2 (en) | 2005-07-29 | 2014-11-11 | Vertos Medical, Inc. | Percutaneous tissue excision devices and methods |
| US8894653B2 (en) | 2005-07-29 | 2014-11-25 | Vertos Medical, Inc. | Percutaneous tissue excision devices and methods |
| US8696671B2 (en) | 2005-07-29 | 2014-04-15 | Vertos Medical Inc. | Percutaneous tissue excision devices |
| US20070123890A1 (en) * | 2005-11-04 | 2007-05-31 | X-Sten, Corp. | Tissue retrieval devices and methods |
| US7942830B2 (en) | 2006-05-09 | 2011-05-17 | Vertos Medical, Inc. | Ipsilateral approach to minimally invasive ligament decompression procedure |
| US8608762B2 (en) | 2006-05-09 | 2013-12-17 | Vertos Medical, Inc. | Translaminar approach to minimally invasive ligament decompression procedure |
| US20090036936A1 (en) * | 2006-05-09 | 2009-02-05 | Vertos Medical, Inc. | Translaminar approach to minimally invasive ligament decompression procedure |
| US8734477B2 (en) | 2006-05-09 | 2014-05-27 | Vertos Medical, Inc. | Translaminar approach to minimally invasive ligament decompression procedure |
| USD620593S1 (en) | 2006-07-31 | 2010-07-27 | Vertos Medical, Inc. | Tissue excision device |
| USD606654S1 (en) | 2006-07-31 | 2009-12-22 | Vertos Medical, Inc. | Tissue excision device |
| US20080221383A1 (en) * | 2007-02-12 | 2008-09-11 | Vertos Medical, Inc. | Tissue excision devices and methods |
| WO2009024275A1 (en) * | 2007-08-20 | 2009-02-26 | Ics Innovative Care Systems Andernach Gmbh | Water- and active ingredient-containing gel |
| US20110182955A1 (en) * | 2007-08-20 | 2011-07-28 | Michael Roreger | Water- and active ingredient-containing gel |
| WO2009038030A1 (en) * | 2007-09-20 | 2009-03-26 | Fujifilm Corporation | Gel sheet and sheet-like cosmetic material using the same |
| WO2009037947A3 (en) * | 2007-09-20 | 2009-07-23 | Fujifilm Corp | Adhesive gel sheet for living organisms and sheet form cosmetics comprising the same |
| US20100221306A1 (en) * | 2007-09-20 | 2010-09-02 | Fujifilm Corporation | Adhesive gel sheet for living organisms and sheet form cosmetics comprising the same |
| US20090110656A1 (en) * | 2007-10-31 | 2009-04-30 | Lemke Sarah A | Skin cooling composition |
| WO2009057000A3 (en) * | 2007-10-31 | 2009-09-11 | Kimberly-Clark Worldwide, Inc. | Skin cooling composition |
| US20090118709A1 (en) * | 2007-11-06 | 2009-05-07 | Vertos Medical, Inc. A Delaware Corporation | Tissue Excision Tool, Kits and Methods of Using the Same |
| USD598549S1 (en) | 2008-09-16 | 2009-08-18 | Vertos Medical, Inc. | Surgical trocar |
| USD621939S1 (en) | 2008-10-23 | 2010-08-17 | Vertos Medical, Inc. | Tissue modification device |
| USD619253S1 (en) | 2008-10-23 | 2010-07-06 | Vertos Medical, Inc. | Tissue modification device |
| USD619252S1 (en) | 2008-10-23 | 2010-07-06 | Vertos Medical, Inc. | Tissue modification device |
| USD611146S1 (en) | 2008-10-23 | 2010-03-02 | Vertos Medical, Inc. | Tissue modification device |
| USD610259S1 (en) | 2008-10-23 | 2010-02-16 | Vertos Medical, Inc. | Tissue modification device |
| US10433700B2 (en) | 2013-11-27 | 2019-10-08 | Kimberly-Clark Worldwide, Inc. | Multi-purpose tough stain removal articles |
| KR20180075670A (en) * | 2015-11-30 | 2018-07-04 | 킴벌리-클라크 월드와이드, 인크. | Structure containing heat-sensitive gel |
| GB2557810A (en) * | 2015-11-30 | 2018-06-27 | Kimberly Clark Co | Structures containing thermo-sensitive gels |
| US10406079B2 (en) | 2015-11-30 | 2019-09-10 | Kimberly-Clark Worldwide, Inc. | Structures containing thermo-sensitive gels |
| WO2017095366A1 (en) * | 2015-11-30 | 2017-06-08 | Kimberly-Clark Worldwide, Inc. | Structures containing thermo-sensitive gels |
| KR102104454B1 (en) | 2015-11-30 | 2020-04-24 | 킴벌리-클라크 월드와이드, 인크. | Structure containing thermosensitive gel |
| GB2557810B (en) * | 2015-11-30 | 2021-11-24 | Kimberly Clark Co | Structures containing thermo-sensitive gels |
| US12102348B2 (en) | 2016-09-07 | 2024-10-01 | Vertos Medical, Inc. | Percutaneous lateral recess resection methods and instruments |
| CN112029118A (en) * | 2020-08-27 | 2020-12-04 | 新疆赛诺凯生物科技有限公司 | Wood vinegar-carbon aerogel composite hydrogel film and preparation method and application thereof |
| US12324572B2 (en) | 2022-06-16 | 2025-06-10 | Vertos Medical, Inc. | Integrated instrument assembly |
| US12342999B2 (en) | 2022-06-16 | 2025-07-01 | Vertos Medical, Inc. | Integrated instrument assembly |
| US12465342B2 (en) | 2022-06-16 | 2025-11-11 | Vertos Medical, Inc. | Integrated instrument assembly |
| US12471899B2 (en) | 2022-06-16 | 2025-11-18 | Vertos Medical, Inc. | Integrated instrument assembly |
| US12496085B2 (en) | 2024-09-05 | 2025-12-16 | Vertos Medical, Inc. | Percutaneous lateral recess resection methods and instruments |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005016305A1 (en) | 2005-02-24 |
| KR100506543B1 (en) | 2005-08-05 |
| EP1653921A1 (en) | 2006-05-10 |
| JP2007502269A (en) | 2007-02-08 |
| RU2006107928A (en) | 2007-09-20 |
| RU2320318C2 (en) | 2008-03-27 |
| CN1835734A (en) | 2006-09-20 |
| US20070280974A1 (en) | 2007-12-06 |
| CN100467011C (en) | 2009-03-11 |
| KR20050017556A (en) | 2005-02-22 |
| EP1653921A4 (en) | 2010-12-08 |
| JP4959328B2 (en) | 2012-06-20 |
| EP1653921B1 (en) | 2015-11-18 |
| US8663664B2 (en) | 2014-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20050037079A1 (en) | Temperature sensitive state-changing hydrogel composition and method for preparation | |
| KR101774342B1 (en) | Hydrogel maskpack composition, Hydrogel maskpack and the preparing method thereof | |
| DE69014614T2 (en) | Delayed release wound dressing formulations and their use. | |
| CN101926833B (en) | Hydrogel patch and preparation method thereof | |
| CN101966339B (en) | Framework material adapted for medical plaster | |
| CN101690818A (en) | Cataplasm matrix and preparation method thereof | |
| de Lafuente et al. | Preparation and evaluation of caffeine bioadhesive emulgels for cosmetic applications based on formulation design using QbD tools | |
| JP3051215B2 (en) | Hyaluronic acid gel and method for producing the same | |
| CN103211753B (en) | A kind of gel substrate | |
| KR101739106B1 (en) | Cream type hydrogel pack manufacturing method therof | |
| CN106562894B (en) | Whitening, anti-aging, anti-allergic hesperidin composition and use and preparation | |
| JP5350575B2 (en) | Sheet-like pack and method for producing the same | |
| CN109316628A (en) | A kind of gel and its preparation method and application | |
| CN114699332B (en) | Liposome temperature-changing gel mask and preparation method thereof | |
| Cally et al. | Thermogelling Polymers and Their History | |
| Zalivskaya et al. | Comparative characteristics of gel bases for semisolid dosage forms | |
| CN116785215B (en) | A ginseng extract composition nanosystem and its preparation method and application | |
| EP1850889A2 (en) | Depolymerized polysaccharide-based hydrogel adhesive and methods of use thereof | |
| CN114601754B (en) | Organic hydrogen slow release material for external medical cosmetology and preparation method thereof | |
| KR20070069250A (en) | Percutaneous absorption adhesive sheet type cosmetic composition containing liposome-ized nanosolvent and preparation method | |
| KR20200065636A (en) | Manufacturing method for thermo-sensitive hydrogel type mask pack and mask pack manufactured by the same | |
| Bisht et al. | Gel as a topical drug delivery system: a review | |
| CN120227318A (en) | Adapalene external preparation and preparation method thereof | |
| Lv et al. | Thermal-responsive heterogeneous organohydrogels with on-demand oil-release capabilities | |
| TWM652825U (en) | Microcapsule structure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: UGENIC, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SON, TAEWON;YOO, HYUN OH;SUNG, CHANGMO;AND OTHERS;REEL/FRAME:014741/0965;SIGNING DATES FROM 20031024 TO 20031031 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |